MAASH Raises €12.15M for Mycoprotein
MAASH secured €12.15M to scale B2B mycoprotein production for food manufacturers.
Alternative protein funding has cooled, but industrial ingredient production is still moving forward.
What happened
Brussels-based MAASH secured a €12.15M funding package combining equity investment and public financing to scale mycoprotein production for the food industry.
The company is focused on B2B ingredient supply rather than launching another consumer alt-meat brand.
Why it matters
That positioning matters. Food manufacturers need scalable, reliable protein ingredients if alternative protein is going to move beyond niche products.
Mycoprotein can serve as a base ingredient for a range of food applications, making production capacity a key part of the category.
The bigger picture
Food-tech investment is becoming more infrastructure-focused. Instead of only backing branded products, investors and public finance are supporting production platforms that can feed multiple downstream companies.